Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic Variation and Regulation of MICA Alters Natural Killer Cell-Mediated Immunosurveillance in Early-Onset Colorectal Cancer.
McGee HM, Bonner JD, Egelston C, Fu Y, Flores OC, Lindsey S, Shaktah L, Moratalla-Navarro F, Kamal Y, Tsang K, Walker CP, Idos G, McDonnell KJ, Rennert H, Barry EL, Brenner H, Buchanan DD, Campbell PT, Chan AT, Chang-Claude J, Figueiredo JC, Gago-Dominguez M, Hoffmeister M, Hsu L, Huyghe JR, Jenkins MA, Le Marchand L, Lenz HJ, Li L, Lindblom A, Liu Ruby YR, Lynch BM, Newton CC, Offit K, Ogino S, Pamplona RS, Pellatt AJ, Pharoah PDP, Phipps A, Reynaga L, Templeton A, Um CY, Wolk A, Woods MO, Wu AH, Yun Y, Zheng W, Williams TM, Conti DV, Peters U, Lejbkowicz F, Greenson JK, Schmit SL, Gauderman WJ, Hamilton SR, Moreno V, Rennert G, Gruber SB. McGee HM, et al. Among authors: egelston c. medRxiv [Preprint]. 2024 Sep 26:2024.09.22.24314127. doi: 10.1101/2024.09.22.24314127. medRxiv. 2024. PMID: 39464256 Free PMC article. Preprint.
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial.
Dorff TB, Blanchard MS, Adkins LN, Luebbert L, Leggett N, Shishido SN, Macias A, Del Real MM, Dhapola G, Egelston C, Murad JP, Rosa R, Paul J, Chaudhry A, Martirosyan H, Gerdts E, Wagner JR, Stiller T, Tilakawardane D, Pal S, Martinez C, Reiter RE, Budde LE, D'Apuzzo M, Kuhn P, Pachter L, Forman SJ, Priceman SJ. Dorff TB, et al. Among authors: egelston c. Nat Med. 2024 Jun;30(6):1636-1644. doi: 10.1038/s41591-024-02979-8. Epub 2024 Jun 12. Nat Med. 2024. PMID: 38867077 Free PMC article. Clinical Trial.
Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy.
Alcantara MB, Tang WS, Wang D, Kaniowski D, Kang E, Dizman N, Chehrazi-Raffle A, Meza L, Zengin Z, Hall J, Hsu J, Egelston C, Moreira D, Horsager A, Pal SK, Kortylewski M. Alcantara MB, et al. Among authors: egelston c. Front Immunol. 2024 Jan 8;14:1274781. doi: 10.3389/fimmu.2023.1274781. eCollection 2023. Front Immunol. 2024. PMID: 38259453 Free PMC article.
CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.
Yuan Y, Egelston C, Colunga Flores O, Chaurasiya S, Lin D, Chang H, Chong LMO, Seiz A, Shah M, Meisen WH, Tang A, Martinez N, Pickett W, Murga M, Yost SE, Stewart D, Zhang J, Ede N, Modi B, Kessler J, Rand J, Fong Y. Yuan Y, et al. Among authors: egelston c. Ther Adv Med Oncol. 2023 Nov 10;15:17588359231210675. doi: 10.1177/17588359231210675. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 38028143 Free PMC article.
33 results